Santen Pharmaceutical Co., Ltd. (SNPHY)
R&D to Revenue
8.98%
Fiscal year · Period ending:

SNPHY R&D to Revenue
What is r&d to revenue?
R&D spending as percentage of revenue.
SNPHY r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.
| Period ending | R&D to Revenue | Change |
|---|---|---|
| 8.979% | +1.16 pts | |
| 7.8222% | −0.36 pts | |
| 8.1807% | −1.96 pts | |
| 10.1409% | +0.23 pts | |
| 9.9066% | +0.25 pts | |
| 9.6601% | +0.27 pts | |
| 9.3892% | −0.49 pts | |
| 9.8827% | −0.63 pts | |
| 10.512% | −0.58 pts | |
| 11.0886% | +0.85 pts | |
| 10.236% | −0.56 pts | |
| 10.7995% | −0.73 pts | |
| 11.5288% | −2.51 pts | |
| 14.0418% | −1.01 pts | |
| 15.0547% | +3.12 pts | |
| 11.931% | −0.84 pts | |
| 12.7701% | −5.39 pts | |
| 18.1631% | +5.65 pts | |
| 12.5162% | −14.68 pts | |
| 27.1941% | +13.00 pts | |
| 14.1986% | +0.59 pts | |
| 13.6133% | — |
Frequently asked questions: SNPHY r&d to revenue
What is Santen Pharmaceutical Co., Ltd. (SNPHY)'s current r&d to revenue?
Santen Pharmaceutical Co., Ltd. (SNPHY)'s latest reported r&d to revenue (Fiscal year) is 8.98% as of Mar 31, 2026. R&D spending as percentage of revenue.
How much historical r&d to revenue data is available for SNPHY?
Stock Alarm Pro provides 22 dated annual fiscal periods observations for Santen Pharmaceutical Co., Ltd. (SNPHY)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare SNPHY's r&d to revenue to peers or set an alert?
You can open SNPHY's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on SNPHY delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance